Descriptor English: | Apolipoprotein A-I | ||||||
Descriptor Spanish: |
Apolipoproteína A-I
| ||||||
Descriptor Portuguese: | Apolipoproteína A-I | ||||||
Descriptor French: | Apolipoprotéine A-I | ||||||
Entry term(s): |
Apo A I Isoproteins Apo A-1 Apo A-I Apo A-I Isoproteins Apo A1 Apo AI ApoA-1 ApoA-I Apolipoprotein A 1 Apolipoprotein A I Apolipoprotein A I Isoprotein 2 Apolipoprotein A I Isoprotein 4 Apolipoprotein A I Isoproteins Apolipoprotein A-1 Apolipoprotein A-I Isoprotein-2 Apolipoprotein A-I Isoprotein-4 Apolipoprotein A-I Isoproteins Apolipoprotein A1 Apolipoprotein AI Apolipoprotein AI Propeptide Pro Apo A I Pro Apolipoprotein A I Pro-Apo A-I Pro-Apolipoprotein A-I Proapolipoprotein AI |
||||||
Tree number(s): |
D10.532.091.200.100 D12.776.070.400.200.100 D12.776.521.120.200.100 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D016632 | ||||||
Scope note: | The most abundant protein component of HIGH DENSITY LIPOPROTEINS or HDL. This protein serves as an acceptor for CHOLESTEROL released from cells thus promoting efflux of cholesterol to HDL then to the LIVER for excretion from the body (reverse cholesterol transport). It also acts as a cofactor for LECITHIN CHOLESTEROL ACYLTRANSFERASE that forms CHOLESTEROL ESTERS on the HDL particles. Mutations of this gene APOA1 cause HDL deficiency, such as in FAMILIAL ALPHA LIPOPROTEIN DEFICIENCY DISEASE and in some patients with TANGIER DISEASE. |
||||||
Allowable Qualifiers: |
AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BI biosynthesis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis DE drug effects DF deficiency EC economics GE genetics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PH physiology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UL ultrastructure UR urine |
||||||
Previous Indexing: |
Apolipoproteins (1977-1984) Apolipoproteins A (1985-1991) |
||||||
Public MeSH Note: | 1992; APOLIPOPROTEIN A-I was indexed under APOLIPOPROTEINS A 1985-1991, under APOLIPOPROTEINS 1979-1984 & under APOPROTEINS 1974-1978; PRO-APOLIPOPROTEIN A-I was indexed under APOLIPOPROTEINS A & PROTEIN PRECURSORS 1983-2006; APOLIPOPROTEIN A-I ISOPROTEINS was indexed under APOLIPOPROTEINS A 1980-2006 |
||||||
History Note: | 1992 (1974); for PRO-APOLIPOPROTEIN A-I (NM) use APOLIPOPROTEINS A & PROTEIN PRECURSORS 1983-2006; for APOLIPOPROTEIN A-I ISOPROTEINS (NM) use APOLIPOPROTEINS A 1980-2006 |
||||||
DeCS ID: | 30252 | ||||||
Unique ID: | D016632 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 1992/01/01 | ||||||
Date of Entry: | 1991/01/24 | ||||||
Revision Date: | 2006/07/05 |
-
-
CHEMICALS AND DRUGS
Lipids [D10]Lipids -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins
|
Apolipoprotein A-I
- Preferred
Pro-Apolipoprotein A-I
- Narrower
Apolipoprotein A-I Isoproteins
- Narrower
Apolipoprotein A-I Isoprotein-2
- Narrower
Apolipoprotein A-I Isoprotein-4
- Narrower
Concept UI |
M0025348 |
Scope note | The most abundant protein component of HIGH DENSITY LIPOPROTEINS or HDL. This protein serves as an acceptor for CHOLESTEROL released from cells thus promoting efflux of cholesterol to HDL then to the LIVER for excretion from the body (reverse cholesterol transport). It also acts as a cofactor for LECITHIN CHOLESTEROL ACYLTRANSFERASE that forms CHOLESTEROL ESTERS on the HDL particles. Mutations of this gene APOA1 cause HDL deficiency, such as in FAMILIAL ALPHA LIPOPROTEIN DEFICIENCY DISEASE and in some patients with TANGIER DISEASE. |
Preferred term | Apolipoprotein A-I |
Entry term(s) |
Apo A-1 Apo A-I Apo A1 Apo AI ApoA-1 ApoA-I Apolipoprotein A 1 Apolipoprotein A I Apolipoprotein A-1 Apolipoprotein A1 Apolipoprotein AI |
Concept UI |
M0117573 |
Preferred term | Pro-Apolipoprotein A-I |
Entry term(s) |
Apolipoprotein AI Propeptide Pro Apo A I Pro Apolipoprotein A I Pro-Apo A-I Proapolipoprotein AI |
Concept UI |
M0087284 |
Scope note | Variants of apolipoprotein A-I. They include secreted propeptide form (isoprotein 2), the converted plasma form (isoprotein-4), and those with various substitutions or deletions. |
Preferred term | Apolipoprotein A-I Isoproteins |
Entry term(s) |
Apo A I Isoproteins Apo A-I Isoproteins Apolipoprotein A I Isoproteins |
Concept UI |
M0087282 |
Preferred term | Apolipoprotein A-I Isoprotein-2 |
Entry term(s) |
Apolipoprotein A I Isoprotein 2 |
Concept UI |
M0087283 |
Preferred term | Apolipoprotein A-I Isoprotein-4 |
Entry term(s) |
Apolipoprotein A I Isoprotein 4 |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey